|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Complicated and uncomplicated peptic ulcers in a Danish county 1993- 2002 : a population-based cohort study显示文摘 | Lassen A Hallas J de Muckadell OBS | 2006 | Amer 3' Gastro- enterol2006，101，5： | 1 |
| 2 | Comparison of circulating MMP-9, TIMP-1 and CA19-9 in the detection of pancreatic cancer 显示文摘 | Joergensen MT Brunner N De Muckadell OB | 2010 | Anticancer Res2010，30，2： | 1 |
| 3 | Use of antisecretory medication:a population-based cohort study显示文摘 | Lassen A Hallas J Schaffalitzky de Muckadell OB | 2004 | Aliment Pharmacol Ther2004，20，： | 1 |
| 4 | Eradication of Helicobacter pylori and use of antisecretory drugs:population based cohort study显示文摘 | Lassen A Hallas J de Muckadell OB | 2003 | BMJ2003，327，： | 1 |
| 5 | Randomized trial of stent placed above and across the sphincter of Oddi in malignant bile duct obstruction显示文摘 | Pedersen FM Lassen AT Schaffalitzky de Muckadell OB | 1998 | Gastrointest Endosc1998，48，6： | 1 |
| 6 | A Positive Diagnostic Strategy Is Noninferior to a Strategy of Exclusion for Patients With Irritable Bowel Syndrome显示文摘 | Luise M. Begtrup Anne Line Engsbro Jens Kjeldsen Pia V. Larsen Ove Schaffalitzky de Muckadell Peter Bytzer Dorte E. Jarb?l | 2013 | Clinical Gastroenterology and Hepatology2013，，8： | 1 |
| 7 | High-dose ursodeoxycholic acid in primary sclerosing cholangitis:a 5-year multicenter, randomized, controlled study显示文摘 | Olsson R Boberg KM de Muckadell OS | 2005 | Gastroenterology2005，129，5： | 1 |
| 8 | Microscopic colitis: a missed diagnosis 显示文摘 | Nielsen OH Vainer B Schaffalitzky de Muckadell OB | 2004 | Lancet2004，364，9450： | 1 |
| 9 | Cell-Free Plasma MicroRNA in Pancreatic Ductal Adenocarcinoma and Disease Controls显示文摘 | Anting Liu Carlsen Maiken Thyregod Joergensen Steen Knudsen Ove B. Schaffalitzky de Muckadell Niels H. H. Heegaard | 2013 | Pancreas2013，，7： | 1 |
| 10 | High-dose ursodeoxycholic acid in primary sclerosing cholangi- tis: a 5-year muhicenter, randomized, controlled study 显示文摘 | OLSSON R BOBERG KM DE MUCKADELL OS | 2005 | Gas- troenterology2005，129，5： | 1 |
| 11 | Risk factors for dyspepsia in a general population: Non-steroidal anti-inflammatory drugs, cigarette smoking and unemployment are more important than Helicobacter pylori infection显示文摘 | Mette Wildner-Christensen Jane M? ller Hansen Ove B. Schaffalitzky De Muckadell | 2006 | Scandinavian Journal of Gastroenterology2006，，2： | 1 |
| 12 | The optimal timing for gastroscopy in severe ulcer bleeding is not determined 显示文摘 | Laursen SB Schaffalitzky de Muckadell OB | 2011 | Ugeskr Laeger2011，173，15： | 1 |
| 13 | Risk factors for dyspepsia in a general population:Non-steroidal anti-in- flammatory drugs,cigarette smoking and unemployment are more im- portant than Helicobacter pylori infection显示文摘 | Wildner-Christensen M Hansen JM De Muckadell OBf | 2006 | Scand J Gastroenterol2006，41，2： | 1 |
| 14 | High - dose ursodeoxycholic acid in primary sclerosing cholangitis : a 5 - year muhicenter, randomized, controlled study 显示文摘 | Olsson R Boberg KM de Muckadell OS | 2005 | Gastroenterology2005，129，5： | 1 |
| 15 | 大剂量熊脱氧胆酸对原发性硬化型胆管炎的疗效:一项为期5年的多中心、随机、对照研究显示文摘Background &Aims: There is no medical treatment of proven benefit for primary sclerosing cholangitis. This study aimed at studying the effect of a higher dose of ursodeoxycholic acid than previously used on survival, symptoms, biochemistry, and quality of life in this disease. Methods: A randomized placebo-controlled study was performed in tertiary and secondary gastroenterology units. A total of 219 patients were randomized to 17 to 23 mg/kg body weight per day of ursodeoxycholic acid (n = 110) or placebo (n = 109) for 5 years. Follow-up data are available from 97 patients randomized to ursodeoxycholic acid and for 101 randomized to placebo. Quality of life was assessed by using the Medical Outcomes Study 36-item Short-Form Health Survey. Results: The combined end point “death or liver transplantation”occurred in 7 of 97 (7.2%) patients in the ursodeoxycholic acid group vs 11 of 101 (10.9%) patients in the placebo group (P=.368; 95%confidence interval, -12.2%to 4.7%). The occurrence of liver transplantation as a single end point showed a similar positive trend for ursodeoxycholic acid treatment (5/97 [5.2%] vs 8/101 [7.9%]; 95%confidence interval, -10.4%to 4.6%). Three ursodeoxycholic acid and 4 placebo patients died from cholangiocarcinoma, and 1 placebo patient died from liver failure. Alkaline phosphatase and alanine aminotransferase tende d to decrease during the first 6 months. There were no differences between the 2 groups in symptoms or quality of life. Analyses of serum ursodeoxycholic acid c oncentration gave no evidence that noncompliance may have influenced the results . Conclusions: This study found no statistically significant beneficial effect o f a higher dose of ursodeoxycholic acid than previously used on survival or prev ention of cholangiocarcinoma in primary sclerosing cholangitis. | Olsson R Boberg K.M Schaffalitsky De Muckadell O. 陈云茹 | 2006 | 世界核心医学期刊文摘(胃肠病学分册)2006，0，4： | 1 |
| 16 | Comparison of circulating MMP-9,TIMP-1 and CA19-9 in the detection of pancreatic cancer显示文摘 | Joergensen MT Brünner N De Muckadell OB | | 0，，： | 1 |
| 17 | Meal-Stimulated Secretin Release in Man: Effect of Acid and Bile显示文摘 | O. B. Schaffalitzky de Muckadell J. Fahrenkrug J. Nielsen I. Westphall H. Worning | 1981 | Scandinavian Journal of Gastroenterology1981，，8： | 1 |
| 18 | Pancreatic Response and Plasma Secretin Concentration during Infusion of Low Dose Secretin in Man显示文摘 | Ove B. Schaffalitzky de Muckadell Jan Fahrenkrug Steen Watt-Boolsen Helge Worning | 1978 | Scandinavian Journal of Gastroenterology1978，，3： | 1 |
| 19 | Proton pump inhibitors in peptic ulcer bleeding显示文摘 | Laursen SB Schaffalitzky de Muckadell OB | 2014 | Ugeskr Laeger2014，176，6： | 1 |
| 20 | Gastroesophageal reflux symptoms in a Danish population:a prospective follow-up analysis of symptoms quality of life,and health--care use显示文摘 | HANSEN JM WILDNER-CHRISTENSEN M Schaffalitzky de Muckadell OB | 2009 | Am J Gastroenterol2009，104，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员